Mutations in the CDKL5 gene cause early onset epilepsy, infantile spasms with hypsarrhythmia on the electroencephalogram (EEG) and atypical Rett syndrome. Axial hypotonia, severe developmental delay and autistic spectrum disorder are also frequently found in patients with these mutations 1 . Different epileptic manifestations were described in patients with mutations in the CDKL5 gene, including seizures with onset at the first six months of life, infantile spasms and myoclonic epilepsy 1, 2 . In 2007, the two first Brazilian patients with Rett syndrome and mutations in the MeCP2 gene were reported 3 . Here, we described the clinical condition and characterization of the two first Brazilian patients with CDKL5 mutations, including the first Brazilian case of atypical Rett related to abnormalities in this gene.
Both girls presented severe developmental delay, axial hypotonia, early onset seizures highly resistant to treatment and hypsarrhythmia. Case 2 also presented a Rett-like phenotype. A small mutation in one allele of exon 8 of the CDKL5 gene, c.549dupA, was found in Case 1, and, in Case 2, a mutation in the Xp22.3 locus detected by array-CGH deleted the whole CDKL5 gene in one allele.
In Case 1, an apparently normal development was reported until de age of two months, when the patient was affected by clonic partial evolving to generalized seizures. Case 2, like most cases related to abnormalities in this gene, presented developmental impairment and hypotonia described to be noticed since the first days of life, although the seizures onset occurred later compared to the average rate previously described, at six months 1, 4 . We observed in our patients the three-step epilepsy phenotype recently associated with CDKL5 mutations, both presenting refractory epilepsy with multifocal activity on the EEG, described to be associated to a more severe phenotype. A group of patients with a better outcome was also reported in the literature. In those, "honey-moon" periods, after anticonvulsants introduction, became permanent with complete absence of seizures, even though neurological condition and hypotonia Figure. Patient 2, at three years and six months, presenting elongated skull and prominent ears. Array-CGH showed a 1,6Mb "de novo" deletion at Xp22.13, which included the whole CDKL5 and NHS genes in one allele. DOI: 10.1590/0004-282X20130050
